Your browser doesn't support javascript.
loading
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
Kudo, Masatoshi; Finn, Richard S; Cheng, Ann-Lii; Zhu, Andrew X; Ducreux, Michel; Galle, Peter R; Sakamoto, Naoya; Kato, Naoya; Nakano, Michitaka; Jia, Jing; Vogel, Arndt.
Afiliación
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Finn RS; Division of Hematology and Oncology, Department of Medicine, Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Cheng AL; Department of Oncology, National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan.
  • Zhu AX; Harvard Medical School, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Ducreux M; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.
  • Galle PR; Department of Medical Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Inserm U1279, Villejuif, France.
  • Sakamoto N; Department of Internal Medicine, University Medical Center Mainz, Mainz, Germany.
  • Kato N; Department of Gastroenterology and Hepatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan.
  • Nakano M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Jia J; Chugai Pharmaceutical Ltd, Tokyo, Japan.
  • Vogel A; Hoffmann-La Roche Limited, Mississauga, ON, Canada.
Liver Cancer ; 12(5): 479-493, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37901766
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Liver Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Liver Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón